2-Fluoro-5-methylnicotinonitrile is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both a fluorine atom and a nitrile group, makes it a valuable building block for creating compounds with potential therapeutic properties. It is often employed in the development of drugs targeting central nervous system disorders, cancer, and inflammatory diseases. Additionally, its reactivity allows for further functionalization, enabling the creation of diverse chemical libraries for drug discovery and optimization. Researchers also utilize it in medicinal chemistry to explore structure-activity relationships (SAR) and improve the efficacy and selectivity of drug candidates.